In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Shiseido

This article was originally published in The Rose Sheet

Executive Summary

Newly opened 162,000 sq. ft. manufacturing facility will produce the company's 5S line beginning in 1999, the company said. The 5S line debuted in its New York City flagship store in May and is expected by Shiseido to become its largest brand in the U.S. ("The Rose Sheet" May 25, p. 12). The plant, operational as of June 1, manufactures Benefiance, Vital-Perfection and Pureness and eventually will account for about 35% of Shiseido's production volume in North America. The East Windsor, N.J.-facility will also serve as an R&D center. Production at the new plant, coupled with increased production at existing plants, will increase Shiseido's North American capacity from its current 90 mil. units per year to 200 mil. units per year, the company predicted. Shiseido purchased the facility and 88 acres of surrounding land from Carter-Wallace, AIS and Pipet Ewing in 1997 ("The Rose Sheet" May 12, 1997, In Brief). The purchase and renovation represent an initial investment of $18 mil., the company said...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005494

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel